ABSTRACT
INTRODUCTION
Leprosy, or Hansen's disease, is a chronic infectious disease caused by Mycobacterium leprae (1) . Leprosy is primarily a granulomatous disease of the peripheral nerves and mucosa of the upper respiratory tract; skin lesions are the primary external symptom (2) . Leprosy is still a significant public health problem. Disease prevalence has fallen due to introduction of multidrug therapy (MDT) (3) . Reactions are a characteristic and clinically important aspect of Hansen's disease (1) . Fifty percent will experience reaction after the institution of multidrug therapy. Reaction can be severe and are an important cause of permanent nerve damage in borderline patients (4) . Reactions, a relatively common phenomenon among leprosy patients in treatment, require early detection and proper management to prevent serious sequelae. It is generally accepted that reactional states are immunologically mediated and, as such, usually improve with immunomodulatory treatments such as corticosteroids or thalidomide.
Neopterin is produced chiefly by human macrophages through their activation by T-cell-derived interferon gamma (5) . Determination of neopterin in various body fluids provides a convenient way to monitor early events that are involved in cellmediated immune responses (6) . In malignant neoplasia, elevation of neopterin concentrations in body fluids depends on tumor type (7) .
Chitotriosidase, one of the most quantitative proteins secreted by activated macrophages, is an endoglucosaminidase belonging to family 18 glycosyl hydrolases and cleaves chitin (8-10) . Its activity has been proposed as a biochemical marker of macrophage accumulation in several lysosomal diseases, especially in Gaucher's disease. (11, 12) Recently, Boot et al. (13) have shown that chitotriosidase activity was elevated up to 55-fold in extracts of atherosclerotic tissue, showing a clear connection between chitotriosidase expression and lipid-laden macrophages inside human atherosclerotic vessel wall.
Adenosine deaminase (ADA), an enzyme of purine metabolism, is present in T-lymphocytes and in part regulates the lymphocytes metabolism and is also important for lymphocytic differentiation and growth (14) . Its activity appears to be necessary for an effective immune response as shown by many studies like in combined immunodeficiency disease and in typhoid fever. Besides this, increased activity of serum ADA has also been demonstrated in tubercular pleural effusion and peritoneal tuberculosis (15) . An increased activity of serum ADA has also been demonstrated in leprosy patients. The cellular immune aberration seen in the different types of leprosy may be due to abnormal proliferation of lymphocytes in response to M. leprae (16) . Monocyte chemotactic protein-1 (MCP-1), a member of the small inducible gene (SIG) family, plays a role in the recruitment of monocytes to sites of injury and infection. The gene for MCP1 is on chromosome 17 in region 17q11.2-q12. MPC1 has been found in the joints of people with rheumatoid arthritis where may serve to recruit macrophages and perpetuate the inflammation in the joints (17, 18) . There is no quick and easy method for identification of Mycobacterium Leprae in clinical specimens; also diagnosis of leprosy is based primarily on clinical ground. M.Leprae cannot be cultured in the laboratory (19) . Diagnosis is often confirmed by microscopic observation of acid -fast bacilli in fresh slit skin smears. Since microscopy requires an estimated 10,000 organisms {acid-fast bacilli (AFB)}/g of tissue, staining is positive for most patients with multibacillary, but is frequently negative in paucibacillary cases (20) . A cutaneous nerve biopsy is frequently required to establish the diagnosis of pure neural leprosy (21) . Recently developed molecular techniques have the potential for more sensitive detection of M.Leprae but they are expensive (22) . So, a sensitive and specific method for detection of M. leprae might simplify the diagnosis of leprosy.
The Objective of the present study is to verify the validity of measuring chitotriosidase activity and neopterin level, products of activated macrophages, adenosine deaminase activity and MCP-1 as markers of leprosy and to detect their values in diagnosis of different types of leprosy. 10ml venous blood was collected form each subject and processed as follow; 5 ml. were added to an EDTAcontaining tube. Plasma was separated after centrifugation at 1500g for 10 min and frozen at -70ºC for chitotriosidase activity determination.
SUBJECTS & METHODS
5 ml were collected in sterile test tubes and centrifuged for 10 minutes at 1500 g, serum was separated and kept at-70°C until used for estimation of neopterin, adenosine deaminase and MCP-1 1-Estimation of chitotriosidase enzyme activity according to the method described by Hollak et al. (11) (27) . Results were expressed as international unit (U/L) of enzyme activity of serum. One unit of ADA is defined as the amount of enzyme required to release 1µmol of ammonia/min from adenosine at standard assay conditions.
Statistics:
All the statistical analyses were processed using Statistical Program of Social Sciences (SPSS) for windows, version 10.0. Values of the measured parameters were expressed as mean value ±SD and the difference between groups was determined using unpaired student's t-test for comparing patients' results with controls while paired ttest was used for comparing the results of reactional patients group before and after corticosteroids therapy, and the significance was considered at p values <0.001 up to <0.05.
RESULTS
Plasma chitotriosidase activity was significantly elevated in leprosy patients (132.2±15.8)as compared to healthy controls(18.2±12.7)from the same leprosy endemic area (P<0.001) ( Table 1 . The pathogenesis and thus the clinical features reflect variable degree to which cell-mediated immunity (CMI) is expressed (28) . Lepromatous leprosy (LL) represents a failure of CMI specifically towards M. leprae, with absence of activated lymphocytes and active macrophages, meaning that nerve damage is slow and gradual. In tuberculoid leprosy (TT), CMI is strongly expressed so that the infection is restricted to one or a few skin sites and peripheral nerves. Between those two polar forms lie the borderline forms of the disease, with the extent of the disease reflecting the balance between CMI and the bacillary load (29) . Borderline patients; borderline tuberculoid (BT), borderline borderline (BB), and borderline lepromatous (BL), are immunologically unstable and at risk of developing type 1 reversal reaction which is a delayed hypersensitivity reaction caused by increased recognition of M. leprae antigens in skin and nerves (30) . Type 2 reaction; erythema nodosum leprosum (ENL), is due to immune complex deposition and occurs in BL and LL patients (29) . The tissue damage occurring in leprosy is exacerbated during episodes of reactions (31) . The acute inflammation associated with reactions causes irreversible tissue damage and nerve destruction; thus, early detection of leprosy reactions is a key priority (29) . If reactions are detected early and adequately treated, permanent nerve damage might be prevented (31) . With the current emphasis on the integration of leprosy control activities into the general health-care services (3) , there is a need to laboratory markers to detect leprosy patients at the early stages, to aid clinical diagnosis, to detect reaction early and to monitor treatment efficacy. Several approaches have been attempted, with mixed results.
Chitotriosidase, one of the most quantitative proteins secreted by activated macrophages, is a human chitinase member of family 18 glycosyl hydrolases (8-10) . It is synthesized as a 50-kDa protein containing a 39-kDa N-terminal catalytic domain, a hinge region, and a C-terminal chitin-binding domain. It is predominantly secreted but in part processed into a 39-kDa form that accumulates in lysosomes. In the blood stream, the secretory 50-kDa chitotriosidase occurs predominantly, whereas in tissues, the 39-kDa form is also abundant (10) . Chitotriosidase is synthesized exclusively by activated macrophages, and its activity has been proposed as a biochemical marker of macrophage accumulation in several lysosomal diseases and is a valuable tool for monitoring the efficacy of therapy especially in Gaucher's disease (11) . Increased chitotriosidase activity has been found within atherosclerotic lesions, in which cholesterol-laden foam cells reside (32) . Elevated serum chitotriosidase activity has been reported in sarcoidosis and tuberculous pleural effusions (33-34) .
The crucial role of the macrophage in leprosy prompted us to look at chitotriosidase activity in the plasma of leprosy patients and healthy controls mainly from leprosy endemic areas. In the present study, plasma chitotriosidase activity was elevated in leprosy patients as compared to healthy controls; also, it was elevated in MB patients as compared to PB patients or healthy controls. MB leprosy is characterized by an abundant macrophage infiltrate with many macrophages showing foamy morphology (23) , also, that result was evidenced by Iyer et al. (35) who found positivity for chitotriosidase, which was localized within the macrophages, by immunohistochemical staining of skin biopsies from 6 MB patients (LL/BL) with high plasma chitotriosidase activity. This suggested that these macrophages are the active producers of chitotriosidase activity detected in MB serum. A subset of CD68+ macrophages was positive for chitotriosidase.
(35)
Similar observations have also been reported for foamy macrophages in atherosclerotic plaques, where only a sub-population of the cells was positive for chitotriosidase (13) . In the present work, chitotriosidase activity was higher in reactional leprosy than non-reactional group and that result was in disagreement with the results of Iyer et al. (35) who reported that chitotriosidase activity is independent of the reaction state in the leprosy patients. This controversy might be due to the difference in the number of the cases examined by both studies, the stage of reaction at which the samples were taken or the different duration of illness. Also, chitotriosidase activity was higher in ENL as compared to patients with reversal reaction and healthy control. RR patients showed manifest lowering of chitotriosidase activity as compared to ENL patients but it was significantly higher than healthy control group. These results were in disagreement with the results of Iyer et al. (35) as they reported lowering of chitotriosidase activity of RR group but with insignificant difference compared to their control group, that difference might be due to the difference in the number of RR patients as Iyer et al. (35) examined three RR patients only. The results of the current study may reflect the inherently different nature of the two reactions. RR is associated with an increased CMI whereas; ENL is thought to be an immune complex disease with some involvement of the CMI. Chitotriosidase activity declined in reactional leprosy patients on treatment with prednisolone. This was supported by in vitro data showing lack of induction of chitotriosidase during dexamethasone-induced polarization of monocytes to macrophages. The dexamethasonedriven polarization of the macrophages was confirmed, for instance, by analysis of the induction of CD163 at the cell surface (36) . Human chitotriosidase has many pleiotropic effects as it is a component of the innate immunity involved in protection against chitin containing pathogens.
Also, variants of chitotriosidase affecting its activity are associated with Gram-negative bacteremia in children undergoing therapy for acute myeloid leukemia. However, M. leprae is not known to contain chitin in its cell wall/membrane fraction (10,11) . Alternatively, increased chitotriosidase activity in leprosy may be an indirect phenomenon related to lipid overloading of lysosomes in macrophages (32) . Neopterin is a pteridine compound synthesized from guanosine triphosphate (GTP) via GTP cyclohydrolase I in activated macrophages. It is synthesized by macrophages upon stimulation with the T-cell-derived cytokine interferongamma and is indicative of a proinflammatory immune status. Neopterin is considered as an early, specific and sensitive marker of cellmediated immune (CMI) activation (5) . In vivo, determination of neopterin in various body fluids provides a convenient way to monitor early events that are involved in cellmediated immune responses in humans under the control of T helper cells type 1 (6) . In the current study, serum neopterin showed significantly higher level in leprosy patients as compared to healthy controls, also, it was significantly higher in LL, BL and BB as compared to BT and TT. The increased neopterin level in the present study is consistent with increased macrophages activity in leprosy patients as neopterin is a monocyte-macrophage activation product. Also, neopterin has been previously recorded to be elevated in leprosy in general and lepra reaction in particular (6,7) and also in other diseases associated with macrophage activation like tuberculosis (37) .
Neopterin level was significantly higher in MB as compared to HC and PB, also significant difference was found between PB and HC. As CMI plays an important role in determining the leprosy spectrum and PB leprosy is associated with strong CMI, which declines progressively towards the lepromatous end of the spectrum (23, 29) , so, it seems paradoxical that the present study showed higher levels of neopterin in MB patients. These higher neopterin levels could be a result of the sheer large numbers of macrophages recruited in MB leprosy.
On the other hand, PB leprosy has a more limited tissue distribution of macrophages resulting in lower neopterin levels in circulation in PB if compared with MB despite a strong activation of the CMI (38) . Serum neopterin level was significantly elevated in ENL and RR as compared to HC. Reactional leprosy group showed significantly higher neopterin level as compared to non-reactional leprosy group, both were significantly higher than control. The result of the present study was in agreement with those of Hamerlinck et al.
(7) and Faber et al.
(6) who suggested that CMI activation plays a large role in reactional states (39) . Other studies looked at the profiles of serum neopterin associated with the leprosy spectrum and reactions with often contradictory results which may be due to the different patients populations involved in the study, low number of studied reactive group, duration of illness or the use of different method for analysis (35, 36, 38) . In the present study, neopterin level showed significant lowering following corticosteroid treatment of reactional leprosy patients if compared with reactional leprosy patients before corticosteroid therapy. Corticosteroids, the primary treatment modality for reactions (40) , cause a decrease in the number of circulating lymphocytes and monocytes and decreased production of cytokines such as IFN-γ, IL-1, TNF-α and IL-2R (41) and neopterin expression (6,7) . The result of the present study was in agreement with that of Hamerlinck et al.
(7) but it is in disagreement with those of Iyer et al. (35, 36) , such contradictory results may be due to the difference in the timing of taking the blood samples during the course of reaction, the presence of other associated factors affecting the neopterin level, the difference in the number of the patients who was taken in the other study as they examined a smaller number of patients or due to the probable risk for development of subsequent episodes of reaction during the treatment course.
Adenosine deaminase (ADA) (EC 3.5.4.4), an enzyme of purine metabolism, in part regulates the lymphocytes metabolism and is also important for lymphocytic differentiation and growth (14) . It is present in lymphocytes in high concentration. The level of enzyme in T-lymphocytes varies according to cellular differentiation (15, 16) . Increased activity of serum ADA has been demonstrated in lymphocytic proliferative diseases as tubercular pleural effusion (42) and peritoneal tuberculosis (15) . The present work showed that serum ADA activity is significantly higher in leprosy patients in comparison with control group with over predominance in tubercloid leprosy. These results are concomitant with lymphocytic overactivity in tubercloid leprosy. Adenosine deaminase activity was significantly higher in both MB and PB as compared to HC, also, it was significantly higher in PB than in MB, this indicates that ADA level could be used for diagnosis of MB as well as PB because slit skin smear (SSS) is frequently negative in paucibacillary cases (43) . Reactional leprosy group showed significantly higher adenosine deaminase activity as compared to non-reactional leprosy group, both were significantly higher than control. Adenosine deaminase activity was elevated in both ENL and RR as compared to HC, with insignificant difference between both ENL and RR as regard adenosine deaminase activity. Adenosine deaminase activity showed insignificant difference following corticosteroid treatment of reactional leprosy patients when compared with reactional leprosy patients before corticosteroid therapy. Altered serum adenosine deaminase (ADA) levels have been recorded in various diseases involving lymphocytes and/or lymphoreticular system including leprosy (16, 44) . Nigam et al., (45) reported high significant activity of adenosine deaminase in leprosy patient in comparison with control group but with lepromatous leprosy predominance which is in disagreement with the present study results. Also, Nigam et al. (45) reported higher activity of adenosine deaminase in MB and PB which is in agreement with the present study results. Suri Babu et al. (16) observed that serum ADA levels were elevated in tuberculoid as well as lepromatous cases as compared to control subjects. On the other hand, Dayal et al., (44) reported that ADA levels gradually increases from LL to TT spectrum. Chaudhary et al. (46) have also shown that serum ADA levels may not run exactly parallel with the conventional parameters of cell mediated immunity in leprosy patients. Adenosine deaminase level was concerned with the lymphocyte activities which are more predominant in tubercloid leprosy and so, ADA activity might significantly increase in tubercloid leprosy as what occurred in the present study. However, the controversy between the present study results and the other studies may be due to firstly; ADA is also present in monocytes and increases tremendously during their maturation into macrophages (14) . Secondly; Lymphocyte ADA level estimation also incorporates B-lymphocyte ADA which is not at all involved in cell mediated immune response (45) . Thirdly; macrophages activities are more predominant in lepromatous leprosy but not lymphocytes (2,4) . The difference between the results of the present study and other studies (45) might be due to the difference of the duration of illness between patients in those studies also, as the overall activity of the enzyme is elevated in leprosy; the cellular immune aberration seen in the different types of leprosy may be due to abnormal proliferation of different subsets of lymphocytes in response to M. leprae. Increase in ADA activity particularly in lymphocytes has been attributed by various workers to increased lymphocyte proliferation as a result of antigenic stimulation (23) . The present study showed that serum ADA activity increased in leprosy patients particularly more in lepra reactions. This indicates its potential for being used as a marker of leprosy in general and lepra reactions in particular. These results agree with the results of Nigam et al. (45) who found high serum ADA levels in patients of leprosy with reaction. This may be due to increased lymphoreticular activity during the reactional phases and reactional leprosy in comparison with other groups included in the study.
Chemokines are a family of small (8-10 kDa), inducible, secreted cytokines with chemotactic and activating effects on different leucocyte subsets and are divided into C-X-C and C-C subfamilies. Chemokines provide key stimuli for directing leucocytes to areas of injury (47) . MCP-1 is a basic protein consisting of 76 amino acids and is classified as a part of the C-C subfamily of chemokines (CCL2). MCP-1, pro-inflammatory cytokine, is constitutively produced by a variety of cell types, including monocytes, smooth muscle cells and endothelial cells, and its expression can be enhanced following induction by oxidative stress, cytokines or growth factor. MCP1 has been called small inducible cytokine A2 (SCYA2) or monocyte chemotactic and activating factor (MCAF). It exerts strong chemoattractant effects on monocytes, macrophages and lymphocytes (26) . Indeed, MCP-1 shows chemotaxis specific to monocytes and is related to the manifestation of surface desmosomal molecules on monocytes at inflammation sites, association with endothelial cells and exudation into the subendothelium (17, 18) . In the present study, MCP-1 was significantly higher in leprosy patients as compared to healthy controls. It was significantly higher in LL as compared to BL, BB, BT and TT. MCP-1 was significantly higher in MB as compared to HC and PB, also insignificant difference was found between PB and HC. Reactional leprosy group showed insignificant difference in MCP-1 level as compared to non-reactional leprosy and control groups. ENL group showed significant higher level of MCP-1 as compared to RR and HC, also, insignificant difference between RR and control group was shown in the present study. MCP-1 showed insignificant difference following corticosteroid treatment of reactional leprosy patients compared with reactional leprosy patients before corticosteroid therapy.
The high level of MCP-1 in LL in the present study was in agreement with the results of Mendonça et al. (48) who reported that, the immunologic basis of the polar types of leprosy is explained by the differences of cytokine expressions in the lesions and as the skin infiltrating cells of lepromatous leprosy are mainly composed of macrophages, chemokines including MCP-1 seem to be responsible for the recruitment of these cells. Also, the present study results supported by the finding of Kirkaldy et al. (49) who suggested that, the chemokines and their receptors, which are known to chemoattract T lymphocytes and macrophages, are involved in assembling the cellular infiltrate found in lesions across the leprosy spectrum. In the present study, MCP-1 was shown to be raised in type 2 reactions (ENL). That results were expected as ENL is a reaction occurs mostly on top of lepromatous leprosy patients whom MCP-1 was significantly raised and in the present study ENL occurred in 10 patients with lepromatous leprosy. However, the result of the present study is in disagreement with that of Stefani et al. (50) who reported insignificant difference in MCP-1 level between ENL and RR leprosy patients Serum MCP-1 levels are known to be significantly correlated with the serum angiotensin converting enzyme (ACE) levels in sarcoidosis (18) . Serum ACE is known to be elevated in leprosy, and that is roughly proportional to the extent of infection (51) . Therefore, it is conceivable that the elevation of serum MCP-1 in leprosy correlates with the severity of the disease. Although the significance of increased serum MCP-1 in leprosy patients is unknown, the reduction of experimental granuloma by anti-MCP-1 antiserum in vivo suggests that increased serum MCP-1 levels in leprosy are due to granuloma formation (17) .
CONCLUSION
Leprosy is still a significant public health problem. Gharbia is an Egyptian Governorate in the center of Delta which is known to harbor many leprosy patients (52) . Reactional state is a common reason for patients to seek consultation (4) . The goal of this study was to screen some potential blood markers in leprosy in general and in lepra reactions in particular. Plasma chitotriosidase activity and serum neopterin level are potentially useful markers in distinguishing MB from PB leprosy and in monitoring response to therapy in reactional leprosy. Neopterin showed high statistically significant increased levels in patients with paucibacillary leprosy compared to control group. So, neopterin can be used to diagnosis paucibacillary leprosy as slit skin smear (SSS) is frequently negative in paucibacillary cases (43) . Adenosine deaminase is considered as a potentially useful marker in distinguishing TT from other types of leprosy due to lymphocytic over activity in TT and it is useful in differentiation reactional from non reactional leprosy but is not useful in monitoring response to therapy in reactional leprosy. MCP-1 is useful in distinguishing LL and in differentiating MB from PB leprosy and it is considered as a promising marker for detection of ENL. The identification of T1R and T2R markers can contribute to their early diagnosis and monitoring of treatment efficacy. Moreover, in view of the difficulty in obtaining lesional biopsies and peripheral blood mononuclear cells (PBMC) under field conditions and the relative ease of blood assays, measurement of cytokines and other soluble cellular products in circulation was better to be used as an alternative diagnostic and predictive marker. Nevertheless, the association of these markers with disease should be interpreted with caution.
